Watch Ticker

EyePoint Pharmaceuticals, Inc. Common Stock

Go to EyePoint Pharmaceuticals, Inc. Common Stock Website

$10.63

0.56 (5.62%)

Live

Previous Close

$10.06

Day Range

$9.4 - $10.64

Previous Day Range

$9.4259 - $10.1

Market Cap

$668.2 million USD

Day Vol.

643378

Previous Day Vol.

671287

Currency

USD

Primary Exchange

Nasdaq

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Eyepoint Pharmaceuticals - EyePoint to Report Second Quarter 2025 Financial Results on August 6, 2025

EyePoint Pharmaceuticals will host a conference call on August 6, 2025 to discuss Q2 financial results and highlight corporate developments, focusing on their lead product DURAVYU, an investigational sustained delivery treatment for retinal diseases.

Related tickers: EYPT.

Read Full Article

Eyepoint Pharmaceuticals - EyePoint Completes Enrollment of Pivotal Phase 3 Trials for DURAVYU™ in Wet Age-Related Macular Degeneration

EyePoint Pharmaceuticals completed enrollment for its Phase 3 clinical trials of DURAVYU, a potential sustained-delivery treatment for wet age-related macular degeneration, with over 800 patients enrolled across two trials and topline data expected in mid-2026.

Related tickers: EYPT.

Read Full Article

Trending Tickers

Please sign in to view